Edwards Lifesciences (NYSE:EW) yesterday closed the $98 million acquisition of CAS Medical Systems and its non-invasive brain tissue oxygenation monitoring tech. Irvine, Calif.-based Edwards paid $2.45 per share for Branford, Conn.-based Casmed using cash on hand, for an aggregate value of $98.1 million, Casmed said in a regulatory filing. The deal was announced Feb. 12. The […]
CAS Medical Systems Inc.
Edwards Lifesciences (NYSE:EW) said today that it inked a deal to acquire CAS Medical System (NSDQ:CASM) and its non-invasive brain tissue oxygenation monitoring tech for approximately $100 million. Irvine, Calif.-based Edwards said that it will pay $2.45 per share of common stock of Branford, Conn.-based Casmed in the all-cash deal. Edwards said that it currently has a pending FDA […]
Abiomed (NSDQ:ABMD) shares got a jump today from its preliminary fiscal third-quarter numbers and an improved outlook for the rest of its fiscal year. The Danvers, Mass.-based heart pump maker said it expects to post fiscal Q3 sales of roughly $200.6 million, representing a 30.3% increase over its fiscal Q3 top line. Abiomed also raised […]
CAS Medical System‘s (NSDQ:CASM) said yesterday it sold its non-invasive blood pressure monitoring tech portfolio for approximately $4.5 million to SunTech Medical. Through the deal, Branford, Conn.-based CasMed will be eligible for up to an additional $2 million in cash based on sales achievements through June 2019. CasMed said it will provide transition services as the portfolio […]
Trinity Medical Devices said yesterday that it paid $3.35 million for CAS Medical System‘s (NSDQ:CASM) line of neonatal intensive care disposables. The deal includes a an additional $400,000 milestone pegged to sales targets over the next 12 months, Parsippany, N.J.-based Trinity said. “I can’t express enough how pleased we are to complete this transaction,” CEO John Easom said in prepared remarks. […]
Steve Ubl, the longtime CEO at medical device lobby AdvaMed, is reportedly leaving the organization after 17 years to take the top spot at the pharmaceutical industry’s largest trade group, the Pharmaceutical Research and Manufacturers of America or PhRMA. The Hill, citing an unnamed source, said that Ubl “will more than likely” take over as […]
A survey of 158 CEOs and 216 venture capital firms revealed a large gap between the chief executives’ wish list for potential backers and what VCs think the CEOs want.
Startup CEOs in the IT and life science industries want VCs who are "entrepreneur friendly" and "collaborative" without being too hands-on in their approach, according to a survey sponsored by the National Venture Capital Assn.